Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS??? EQUITY

v3.24.1.u1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
AOCI Attributable to Parent
Beginning balance (in shares) at Dec. 31, 2022   65,739,053      
Beginning balance at Dec. 31, 2022 $ 83,219 $ 0 $ 314,884 $ (231,636) $ (29)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common shares from stock option exercises (in shares)   41,175      
Issuance of common shares from stock option exercises 73   73    
Issuance of common shares from the employee stock purchase plan (in shares)   134,336      
Issuance of common shares from the employee stock purchase plan 622   622    
Vesting of restricted stock units (in shares)   586,640      
Common stock withheld related to net settlement of equity awards (in shares)   (163,752)      
Common stock withheld related to net settlement of equity awards (753)   (753)    
Stock-based compensation 4,513   4,513    
Foreign currency translation adjustments, net of tax (34)       (34)
Net unrealized gain (loss) on investments, net of tax 18       18
Net loss (7,859)     (7,859)  
Ending balance (in shares) at Mar. 31, 2023   66,337,452      
Ending balance at Mar. 31, 2023 $ 79,799 $ 0 319,339 (239,495) (45)
Beginning balance (in shares) at Dec. 31, 2023 70,116,357 70,116,357      
Beginning balance at Dec. 31, 2023 $ 78,957 $ 0 341,514 (262,667) 110
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common shares from stock option exercises (in shares) 60,548 60,548      
Issuance of common shares from stock option exercises $ 291   291    
Issuance of common shares from the employee stock purchase plan (in shares)   113,959      
Issuance of common shares from the employee stock purchase plan $ 1,020   1,020    
Vesting of restricted stock units (in shares)   1,205,838      
Common stock withheld related to net settlement of equity awards (in shares) (516,331) (516,331)      
Common stock withheld related to net settlement of equity awards $ (6,101)   (6,101)    
Stock-based compensation 6,772   6,772    
Foreign currency translation adjustments, net of tax (238)       (238)
Net unrealized gain (loss) on investments, net of tax (62)       (62)
Net loss $ (7,203)     (7,203)  
Ending balance (in shares) at Mar. 31, 2024 70,980,371 70,980,371      
Ending balance at Mar. 31, 2024 $ 73,436 $ 0 $ 343,496 $ (269,870) $ (190)